Literature DB >> 20236315

Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening.

Fei Xiang1, Yue-Sheng Huang, Xiao-Hua Shi, Qiong Zhang.   

Abstract

Tumour necrosis factor receptor-associated protein 1 (TRAP1) is a mitochondrial chaperone that plays a role in maintaining mitochondrial function and regulating cell apoptosis. The opening of the mitochondrial permeability transition pore (MPTP) is a key step in cell death after hypoxia. However, it is still unclear whether TRAP1 protects cardiomyocytes from hypoxic damage by regulating the opening of the pore. In the present study, primary cultured cardiomyocytes from neonatal rats were used to investigate changes in TRAP1 expression after hypoxia treatment as well as the mechanism and effect of TRAP1 on hypoxic damage. The results obtained showed that TRAP1 expression increased after 1 h of hypoxia and continued to increase for up to 12 h of treatment. Hypoxia caused an increase in cell death and decreased cell viability and mitochondrial membrane potential; overexpressing TRAP1 prevented hypoxia-induced damage to cardiomyocytes. The silencing of TRAP1 induced an increase in cell death and decreased both cell viability and mitochondrial membrane potential in cardiomyocytes under normoxic and hypoxic conditions. Furthermore, cell damage induced by the silencing of TRAP1 was prevented by the mitochondrial permeability transition pore inhibitor, cyclosporin A. These data demonstrate that hypoxia induces an increase in TRAP1 expression in cardiomyocytes, and that TRAP1 plays a protective role by regulating the opening of the mitochondrial permeability transition pore.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236315     DOI: 10.1111/j.1742-4658.2010.07615.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  29 in total

1.  The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.

Authors:  Erin K Butler; Aaron Voigt; A Kathrin Lutz; Jane P Toegel; Ellen Gerhardt; Peter Karsten; Björn Falkenburger; Andrea Reinartz; Konstanze F Winklhofer; Jörg B Schulz
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

2.  New insights into TRAP1 pathway.

Authors:  Danilo Swann Matassa; Maria Rosaria Amoroso; Francesca Maddalena; Matteo Landriscina; Franca Esposito
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

Review 3.  Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases.

Authors:  Thekkuttuparambil Ananthanarayanan Ajith; Thankamani Gopinathan Jayakumar
Journal:  World J Cardiol       Date:  2014-10-26

4.  Downregulation of TRAP1 aggravates injury of H9c2 cardiomyocytes in a hyperglycemic state.

Authors:  Xiaodan Zhang; Zhen Zhong; Wangen Li
Journal:  Exp Ther Med       Date:  2019-08-05       Impact factor: 2.447

5.  Expression of TRAP1 predicts poor survival of malignant glioma patients.

Authors:  Shuai Li; Qingjie Lv; Hanxue Sun; Yixue Xue; Ping Wang; Libo Liu; Zhiqing Li; Zhen Li; Xin Tian; Yun-Hui Liu
Journal:  J Mol Neurosci       Date:  2014-09-05       Impact factor: 3.444

6.  Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.

Authors:  Ru Chen; Sheng Pan; Keith Lai; Lisa A Lai; David A Crispin; Mary P Bronner; Teresa A Brentnall
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

7.  Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer.

Authors:  Qingjie Lv; Hanxue Sun; Chengcheng Cao; Bo Gao; Yafei Qi
Journal:  Tumour Biol       Date:  2015-09-25

Review 8.  Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells.

Authors:  Andrea Rasola; Len Neckers; Didier Picard
Journal:  Trends Cell Biol       Date:  2014-04-11       Impact factor: 20.808

9.  Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis.

Authors:  Soichiro Yoshida; Shinji Tsutsumi; Guillaume Muhlebach; Carole Sourbier; Min-Jung Lee; Sunmin Lee; Evangelia Vartholomaiou; Manabu Tatokoro; Kristin Beebe; Naoto Miyajima; Robert P Mohney; Yang Chen; Hisashi Hasumi; Wanping Xu; Hiroshi Fukushima; Ken Nakamura; Fumitaka Koga; Kazunori Kihara; Jane Trepel; Didier Picard; Leonard Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-05       Impact factor: 11.205

Review 10.  Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.

Authors:  Rianne Nederlof; Otto Eerbeek; Markus W Hollmann; Richard Southworth; Coert J Zuurbier
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.